William Blair Reiterates Brickell Biotech (BBI) at Outperform, Sees "Strong Risk/Reward Profile" at Current Valuations
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Brickell Biotech Inc. (NASDAQ: BBI). The analyst quotes: "With what ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
